AstraZeneca's experimental drug disappoints in breast cancer …
WEB1 day ago · AstraZeneca said on Monday its experimental precision drug developed with Japan's Daiichi Sankyo did not significantly improve overall survival for patients with a type of breast cancer in a late ...
Latest Trial Setback For AstraZeneca's Dato-DXd, The Drug Fails …
WEB20 hours ago · Monday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the TROPION-Breast01 Phase 3 trial of datopotamab deruxtecan (Dato-DXd) compared to the investigator’s choice of chemotherapy.
FluMist approved for self-administration in the US - astrazeneca.com
WEB3 days ago · FluMist, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or administered by a parent/caregiver to individuals 2-17 years of age. 1. The approval by the US Food and Drug Administration (FDA) was based on a comprehensive submission, which included results from …
AstraZeneca to withdraw Covid vaccine - BBC News
WEBMay 8, 2024 · After more than three billion doses, the Oxford-AstraZeneca Covid vaccine is being withdrawn. AstraZeneca said it was "incredibly proud" of the vaccine, but it had made a commercial decision....
AstraZeneca sets ambition to deliver $80 billion Total Revenue by …
WEBMay 21, 2024 · Today AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8 billion in 2023. This will be achieved through significant growth in its existing oncology, biopharmaceuticals and rare disease portfolio, and by launching an expected 20 new medicines before the end of the decade.
AstraZeneca faces legal challenge over Covid vaccine - BBC News
WEBNov 9, 2023 · AstraZeneca is facing legal action over its Covid vaccine, by a man who suffered severe brain injury after having the jab in April 2021. Father-of-two Jamie Scott suffered a blood clot that...
AstraZeneca to withdraw Covid vaccine - BBC
WEBMay 8, 2024 · After more than three billion doses, the Oxford-AstraZeneca Covid vaccine is being withdrawn. AstraZeneca said it was "incredibly proud" of the vaccine, but it had made a commercial decision....
AstraZeneca withdraws COVID vaccine from European market | AP ... - AP News
WEBMay 9, 2024 · The EU regulator concluded AstraZeneca’s shot didn’t raise the overall risk of clots, but doubts remained. Partial results from its first major trial — which Britain used to authorize the vaccine — were clouded by a manufacturing mistake that researchers didn’t immediately acknowledge.
AstraZeneca: US data shows vaccine effective for all adults
WEBWASHINGTON (AP) — AstraZeneca reported Monday that its COVID-19 vaccine provided strong protection among adults of all ages in a long-anticipated U.S. study, a finding that could help rebuild public confidence in the shot around the world and move it a step closer to clearance in the U.S.
Covid vaccine: US trial of AstraZeneca jab confirms safety
WEBMar 22, 2021 · Results from the long-awaited US trial of the Oxford-AstraZeneca Covid vaccine are out and confirm that the shot is both safe and highly effective. More than 32,000 volunteers took part, mostly...
- Some results have been removed